Status:
COMPLETED
AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.
Lead Sponsor:
Mayo Clinic
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (A...
Detailed Description
The purpose of the study is to investigate whether preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progre...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patients with VAD in place who are admitted to the hospital for acute medical illness during the study period. For those with multiple admissions during the study period only the first admission will be studied.
- Patients who are able to give consent. In case of patients that are mentally impaired we will obtain consent from power of attorney and when patients regain intact mental capacity we will reobtain consent from the patient.
- Exclusion criteria:
- Patients on dialysis (hemodialysis or peritoneal dialysis).
Exclusion
Key Trial Info
Start Date :
May 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2019
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT03236103
Start Date
May 19 2017
End Date
April 8 2019
Last Update
October 10 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
3
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905